Separated registration system premature to implement soon.

Published: 2006-01-23 06:58:00

Updated: 2006-01-23 06:58:00

The domestic pharmaceutical manufacturers group expressed an opposing attitude against the impending government movement of revising the current Pharmaceutical Affairs Act, key subjects of which are now under the process of the public hearing, claiming that the separated registration system for t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK